<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<measures><measure><type>Main</type><parent-measure></parent-measure><title>The number of cross-discipline reviews led by OCP as cross-disciplinary team leaders (CDTLs)</title><dictionary>The Cross-Discipline Team Leader (CDTL) is a new concept under 21st Century Review Process in CDER.  CDTLs, generally appointed based on the nature of the submissions, e.g., serve as the medical team leader for applications containing clinical data.   The CDTL provides day-to-day management of the review, performs a secondary review of the overall application taking into account all discipline reviews and recommendations, and maintains consistency of regulatory decisions and direction of the review. This measure reflects the number of submissions where clinical pharmacology may have a bigger impact than other disciplines.</dictionary>
<dictionary>&lt;br&gt;This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research. &lt;/b&gt;</dictionary>
<footnotes><note></note></footnotes><measure-description></measure-description><chart-type>column</chart-type><chart-color></chart-color><right-min></right-min><right-max></right-max><fiscal-year><chart-min></chart-min><chart-max></chart-max><title>2011</title><target-header></target-header><target-description>Performance measure implemented April 2011</target-description><summary></summary><time><frame>Apr 2011</frame><target></target><value>1</value></time><time><frame>May 2011</frame><target></target><value>0</value></time><time><frame>Jun 2011</frame><target></target><value>0</value></time><time><frame>Jul 2011</frame><target></target><value>1</value></time><time><frame>Aug 2011</frame><target></target><value>1</value></time><time><frame>Sep 2011</frame><target></target><value>1</value></time></fiscal-year><fiscal-year><chart-min></chart-min><chart-max></chart-max><title>2012</title><target-header></target-header><target-description></target-description><summary>FY 2012 YTD: 5</summary><time><frame>Oct 2011</frame><target></target><value>2</value></time><time><frame>Nov 2011</frame><target></target><value>3</value></time><time><frame>Dec 2011</frame><target></target><value>0</value></time><time><frame>Jan 2012</frame><target></target><value></value></time><time><frame>Feb 2012</frame><target></target><value></value></time><time><frame>Mar 2012</frame><target></target><value></value></time><time><frame>Apr 2012</frame><target></target><value></value></time><time><frame>May 2012</frame><target></target><value></value></time><time><frame>Jun 2012</frame><target></target><value></value></time><time><frame>Jul 2012</frame><target></target><value></value></time><time><frame>Aug 2012</frame><target></target><value></value></time><time><frame>Sep 2012</frame><target></target><value></value></time></fiscal-year></measure><related-links><link><url>http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htm</url><text>FDA-TRACK CDER Dashboard</text></link></related-links><glossary><word><text>word text</text><definition>word definition</definition></word></glossary></measures>
    






